Free Pharmacist CPE 2017‑2018 | CMEList.com 

 


Resisting Arrest: Treating Complicated Gram-negative Infections
Free Infectious Disease CME Posted by...Bernard Sklar, MD. img = images-doctorschannel/Resisting-Arrest_300x185.jpg alt text = Free Infectious Disease CME
Free CME Credit Hours...0.75.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Physicians, pharmacists, and other health professionals involved in the management of Gram-negative infections.
Educational material last updated...December 13, 2016.
CME Credit Expires...December 12, 2017.
Financial Support...Merck & Co., Inc.
Resisting Arrest: Treating Complicated Gram-negative Infections consists of 3 brief presentations about Gram-negative infections.
Upon successful completion of Resisting Arrest: Treating Complicated Gram-negative Infections, you should be better able to:
• Assess the burden and costs to the health care system when infections become resistant to antimicrobial therapy.
• Review the mechanisms of resistance as they pertain to the antimicrobial treatment of Gram-negative infections.
• Examine the spectrum of activity demonstrated by current antimicrobials in the treatment of common and complicated Gram-negative infections.
• Compare the safety and efficacy of antimicrobial agents used to treat complicated Gram-negative infections.

Basal Insulin as a Foundation of Diabetes Treatments: Innovative Approaches Free Diabetes CME
Live online February 1, 2017and April 5, 2017  and available on demand through October 5, 2017.
Posted by...Bernard Sklar, MD.
Free Diabetes CME Credit hours...2.0. (1,0 hour for each)
CME Credits Awarded by....Primary Care Network.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for endocrinologists, primary care clinicians, physician assistants, nurse practitioners, pharmacists, certified diabetes educators and other health care providers who provide frontline glycemic management for type 2 diabetes and related conditions.
Educational material updated....April 5, 2017.
Expiration of CME credit...October 5, 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.
After viewing the two presentations of Basal Insulin as a Foundation of Diabetes Treatments,  you will be better able to:
• Describe the pharmacokinetics and pharmacodynamics of the newer ultra-long basal and follow-on biologic ("biosimilar") insulin formulations and how these differ from older formulations
• Determine indications and methods to transition from analog basal insulin to ultra-long basal insulins and follow-on biologic ("biosimilar") basal insulins to help achieve individualized patient treatment goals
• Examine the evidence-based, guideline-driven protocols for therapeutic advancement to basal insulin therapy alone or in combination with other treatment modalities to achieve individualized patient goals
• Identify potential patient, provider, and health care system barriers to initiation and titration of established and newer basal insulins, and methods to overcome these barriers

An Update on Fixed-Dose LAMA/LABA Inhalers in COPD
Posted by...Bernard Sklar, MD. Free Lung Cancer CME
Free Pulmonology CME Credit hours...2.0.
CME Credits Awarded by....The France Foundation
Cost...........Free.
Instruction Type...Text-and-Graphics.
Target Audiences...This program is intended for health care professionals who treat and manage patients with COPD.
Educational material updated....September 30, 2016.
Expiration of CME credit...September 29, 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc.
An Update on Fixed-Dose LAMA/LABA Inhalers in COPD consists of written presentations by 4 experts on the use of Fixed-Dose Inhalers in COPD
Upon completion of An Update on Fixed-Dose LAMA/LABA Inhalers in COPD, you should be able to:
• Evaluate key efficacy data from clinical trials on new and emerging fixed-dose LAMA/LABA inhalers in COPD.
• Evaluate key safety data from clinical trials on new and emerging fixed-dose LAMA/LABA inhalers in COPD.
• Apply information on the efficacy and safety of new/emerging LAMA/LABA inhalers in COPD to specific clinical scenarios.

Updates in Migraine Headaches: Best practices and Emerging Therapies in Treatment and Prevention 
Posted by...Bernard Sklar, MD. Free Neurology CME Free Pain Management CME
Free Neurology and Pain Management CME Credit hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...Healthcare professionals who are: primary care physicians, neurologists, headache specialists, nurse practitioners, physician assistants, nurses, OB-GYN specialists, pharmacists, and those who otherwise commonly care for or clinically encounter patients who may experience migraine headache.
Educational material updated...July 20, 2016.
Expiration of CME credit...July 20, 2018.
Financial Support...AMGEN and Promius.
After viewing Updates in Migraine Headaches, you will be able to:
• Describe the prevalence of migraine symptoms and the impact that these symptoms have on efficacy of anti-migraine therapy and functional status
• Describe the sometimes variable manifestations (e.g., incidence and clinical presentation) of migraine headaches, depending on age and sex
• Recall emerging therapies for the treatment and prevention of chronic migraine headache and anticipate their place in therapy
• Support team-based learning and communication between all clinicians involved with the care of patients suffering with migraines
• Given a series of patient cases, diagnosis and treat migraine headaches by employing current treatment guidelines, using evidence-based therapy algorithms, and providing individualized approaches to care
In order to get credit from ScientiaCME, you must first establish a username and password.

Adult Growth Hormone Deficiency (GHD): Therapeutic Updates, Present Clinical Controversies, and Barriers to Care Free Endocrinology CME
Posted by...Bernard Sklar, MD.
Free Endocrinology CME Credit hours...0.75.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...Healthcare professionals specializing in endocrinology and those who otherwise commonly care for or clinically encounter adult patients with GHD.
Educational material updated...July 12, 2016.
Expiration of CME credit...July 12, 2018.
Financial Support...Novo Nordisk.
After completing Adult Growth Hormone Deficiency (GHD), you will be able to:
• Summarize present guidelines for the diagnosis of GHD
• Describe the underlying pathophysiological and typical clinical features of GHD as they pertain to therapeutic targets.
• Given a patient with GHD, design a pharmacotherapeutic regimen based on his or her clinical presentation.
• Assess and properly manage the significant comorbidities that are associated with GHD and therefore increase mortality in patients with GHD
• Evaluate patient cases during follow-up visits in a manner that optimizes one or more of the following: efficacy, safety, quality of life, or patient education and adherence.
In order to get credit from ScientiaCME, you must first establish a username and password.

HER2+ BRCA INSTANT SYMPOSIUM: Updates on HER2 Positive Breast Cancer Management Free Breast Cancer CME
Live online June 10, 2016, and available on demand through June 10, 2017.
Posted by...Bernard Sklar, MD.
Free Breast Cancer CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for oncologists, hematologist-oncologists, radiation oncologists, breast surgeons, oncology nurse practitioners, pharmacists, and other healthcare professionals who treat patients with breast cancer.
Educational material updated...June 10, 2016.
Expiration of CME credit...June 10, 2017.
Financial Support...Genentech.
Updates on HER2 Positive Breast Cancer Management consists of a single lecture with discussion:
Updates on HER2 Positive Breast Cancer Management
At the conclusion of Updates on HER2 Positive Breast Cancer Management, you will be able to:
• Summarize the efficacy and safety of new and emerging treatment approaches for HER2 positive breast cancer in the neoadjuvant, adjuvant and metastatic settings
• Evaluate therapeutic challenges associated with HER2-targeted treatment, including resistance, toxicity and optimal duration of treatment

Alzheimer Disease (AD) and Its Complications: Best Practices, Emerging Therapies, and Barriers to Care Alzheimer's Disease CME 
Posted by...Bernard Sklar, MD.
Alzheimer's Disease CME Credit hours...1.0. 
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture.
Target Audiences...Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.
Educational material updated...December 21, 2015.
Expiration of CME credit...December 21, 2017.
Financial Support...AVANIR.
Topics covered in Alzheimer Disease (AD) and Its Complications include:
Epidemiology of and risk factors for Alzheimer Disease (AD), Symptomatology and diagnosis of AD, Treatment in patients with AD, Complications and barriers to optimal care in patients with AD and many more.
After completing Alzheimer Disease (AD) and Its Complications, you will be able to:
• Describe what is presently known about the pathophysiology of AD and the challenges associated with diagnosis and treatment of AD.
• Evaluate a treatment plan for a specific patient based on degree of AD to optimize safety and efficacy, suggesting modifications for improvement.
• Identify the present treatment options currently available for management of AD and apply them to patient cases using evidence-based medicine.
• Describe emerging drug therapies in the treatment of AD.
• Describe barriers to care and suggest therapies for treating cognitive and behavioral complications secondary to AD
In order to get credit from ScientiaCME, you must first establish a username and password.

Heart Failure: Best Practices, Emerging Therapies, and Barriers to Care Cardiology CME
Posted by...Bernard Sklar, MD.
Free Pharmacy CPE Credit hours...1.0.
CPE Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...Pharmacists who have an interest in the treatment of Heart Failure.
Educational material updated...12/29/15.
Expiration of CME credit...12/29/17.
Financial Support...AMGEN.
By the end of Heart Failure: Best Practices, Emerging Therapies, and Barriers to Care, you will be able to:
• Describe the pathophysiology of Heart Failure (HF).
• Identify the present treatment options currently available for management of HF and apply them to patient cases using evidence-based medicine.
• Describe emerging drug therapies in the treatment of HF
• Evaluate a treatment plan for a specific patient based on degree of HF to optimize safety and efficacy, suggesting modifications for improvement.
• Describe barriers to care in HF.
In order to get credit from ScientiaCME, you must first establish a username and password.

Scientia CME Neuropsychiatry - Psychiatry Free Psychiatry CME ScientiaCME Psychiatry 
Posted by...Bernard Sklar, MD.
CME Credit Hours...4.75.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...PSYCHIATRY.
CME Credit Expires...Two years after release.
Financial Support...Various commercial supporters.